Manufactured by Summit, N.J.-based Celgene Corp., Otezla demonstrated improvements in symptoms of psoriatic arthritis, such as tender and swollen joints and physical function, in clinical trials.
More Articles on FDA Approvals:
FDA Approves Xolair for Chronic Hives
FDA Approves Neuraceq for Brain Imaging
FDA Approves Implantable Device for Certain Type of Hearing Loss
Register to Attend Webinar
Presenters:
Allen Passerallo, Vizient Inc.|Ian O’Malley, University of Chicago Medicine
Next Up in Supply Chain
-
Minneapolis-based Fairview Health Services is advancing plans for a $100 million centralized laboratory in Roseville, Minn., that will expand its…
-
Siemens Healthineers debuted the Accela radiotherapy system Sept. 27 at the American Society for Radiation Oncology’s annual meeting in Boston. …
-
Vizient, HealthTrust and Premier now serve more than 80% of U.S. hospitals, up from 62% a decade ago. Hospital supply…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
